AYTU Aytu BioPharma, Inc.

NASDAQ
$2.28

Aytu BioPharma, Inc. (AYTU) is expected to report earnings on December 22, 2026, after the market close. The consensus earnings estimate is a loss of $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.6% since its last earnings release on September 22, 2026.

Aytu BioPharma Beat Consensus Estimates
Tuesday, September 22, 2026 · 4:05 PM ET
Earnings Date
1st Quarter, Sep 2026
Dec 22
Tuesday · 7:20 PM ET
Earnings Whisper
-
vs ($0.01)
Rev est $17.18M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.29

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Aytu BioPharma, Inc.

Aytu BioPharma is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.